Heart Failure -> Heart Failure Management: -> Monitoring D-AB14 - Atrial Fibrillation in Heart Failure (ID 43) Abstract Plus

D-AB14-02 - Insulin-like Growth Factor-binding Protein-7 And N-terminal Pro-brain Natriuretic Peptide To Predict Congestive Heart Failure Hospitalizations In Patients With Atrial Fibrillation (ID 1435)

Abstract

Background: Congestive heart failure (CHF) has become the most common cardiovascular complication in patients with atrial fibrillation (AF). Accurately predicting CHF in AF patients is a clear unmet clinical need.
Objective: To assess the individual and combined value of Insulin-Like Growth Factor-Binding Protein-7 (IGFBP-7) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in identifying AF patients at risk for CHF.
Methods: We analyzed 3,691 prospectively followed AF patients. Information on demographics and co-morbidities were obtained through standardized questionnaires. Levels of IGFBP-7 and NT-proBNP were measured at baseline. Multivariable adjusted Cox-regression analyses were constructed to assess the associations of IGFBP-7 and NT-proBNP levels with CHF.
Results: Mean age was 69±12 years, 1,028 (28%) were women and 879 (24%) had a history of CHF. During 3.7±1.8 years, 385 patients were hospitalized for CHF. The incidence per 1,000 patient-years was 7, 10, 32 and 85 across increasing IGFBP-7 quartiles and 3, 15, 34 and 81 across increasing NT-proBNP quartiles, respectively. Patients with IGFBP-7 and NT-proBNP concentration levels above the biomarker specific median had a higher risk of incident CHF (multivariable adjusted hazard ratio [aHR] 5.87 [95%CI 3.78;9.12]) compared to those with only one of two elevated marker (elevated IGFBP-7 aHR 2.26 [95%CI 1.36;3.75]; elevated NT-proBNP aHR 2.09 [95%CI 1.24;3.54]) or no elevated marker (ref.) [Figure].
Conclusion: IGFBP-7 and NT-proBNP provide strong and additive information in the prediction of CHF among patients with AF. These markers may be helpful to identify AF patients at very high risk of CHF.

Collapse